|
ABOUT COMPANY
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company is headquartered in Bothell, Washington.
|
EARNINGS
Gross Profit (TTM): 27852000
Market Capitalization: 1552180000
Operating Margin (TTM): -0.155
PE Ratio: 284.5
PEG Ratio: 21.6
Profit Margin: 0.0488
Revenue Per Share (TTM): 2.659
Revenue (TTM): 96577000
Quarterly Earnings Growth YOY: 6.4
Quarterly Revenue Growth YOY: 1.997
Trailing PE: 284.5
|
DIVIDENDS
Diluted EPS (TTM): 0.131
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: 2147000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|